In this guide

Fresh healthy meal representing medical weight loss vs diet culture

If you've lost the same 30, 50, or 80 pounds three or four times - keto, Whole30, fasting, points - and it always came back, here's the truth diet culture won't tell you: it's not your willpower. It's your biology.

Quick Read Summary

  • When you lose weight, your body fights back - it slows your metabolism and ramps up hunger hormones for years.
  • That's why most diets fail long-term: you're fighting your own biology with willpower alone.
  • Medical weight loss treats obesity as a chronic condition (like high blood pressure), using GLP-1 medication plus coaching and lab monitoring.
  • It's a long-term tool, not a 12-week fix - stop the medication and the weight usually returns.
  • The medication makes the work possible; it doesn't replace the work.

Why diets stop working

Your body was built to survive food shortages, not to be lean. When you cut calories, it adapts: your metabolism slows down more than your smaller body explains, your hunger hormone (ghrelin) rises, your “I'm full” hormone (leptin) drops, and food becomes more tempting, not less. Worse, these changes can last for years after the weight is gone - researchers found contestants from The Biggest Loser still had suppressed metabolisms six years later. So regaining weight isn't a character flaw. It's the predictable result of fighting your own biology with discipline alone.

What diet culture gets wrong

Most diet programs share one flawed idea: that weight is just about food rules and discipline. They're wrong in four ways - they assume eating is mostly a conscious choice (it isn't; appetite hormones drive most of it), they treat “calories in vs. out” as fixed (your body changes both sides when you diet), they treat regain as a moral failure (it's biology), and they sell 12-week fixes for a lifelong condition. Medical weight loss flips all four.

What the evidence shows

GLP-1 medications work by quieting the appetite and fullness signals that defeat dieters. In the major trials, semaglutide produced about 15% average weight loss and tirzepatide about 20–22% - and semaglutide even cut heart attacks and strokes by about 20% in people with existing heart disease. By comparison, even the best behavioral programs usually produce 4–7% and tend to regain. The point isn't that medication replaces effort - it's that it makes the effort actually stick. Which drug fits whom is covered in semaglutide vs tirzepatide.

What a real program includes

Not every “medical weight loss” offer is the real thing. A clinically sound program includes a thorough intake (history, medications, and baseline labs), a clear medication and dose plan, coaching that protects your muscle and rebuilds eating habits, lab monitoring, and a maintenance plan started on day one. Our program is $299/month and bundles the medication, four coaching sessions a month, labs, and direct clinician access - the same clinician at every visit, no call center. It connects to the same root-cause thinking in our Ann Arbor medical weight loss approach, and we use FDA-approved medications rather than gray-market sources (more on the compounding rules). For more on paying for a program with an HSA or FSA card, see our guide to using an HSA or FSA card for medical weight loss.

The honest limits

Here's what most programs leave out. It doesn't work for everyone - about 10–15% of people don't respond well. It's not a 12-week fix - stop early and you'll likely regain. It doesn't erase the work - if you just eat less of the same food, you'll plateau. It has side effects (nausea, constipation, fatigue, especially while increasing the dose). It costs money ($299/month is real). And it's not right for someone with active disordered eating, which we screen for. What I see in clinic: the people who succeed use the calmer appetite as a window to rebuild habits, add strength training, and fix sleep - not as a free pass.

Frequently Asked Questions

How is this different from “eat less, exercise more”?

That advice is true but incomplete - it ignores the appetite hormones that defeat most people. Medical weight loss adds a tool that quiets those signals, so the eating and exercise changes finally become sustainable instead of a daily fight.

Is it right for me if I “only” need to lose 20 pounds?

These medications are approved for a BMI of 30+, or 27+ with a weight-related condition. If you don't meet that, a structured behavioral plan is usually the right path. We won't prescribe them cosmetically, and we'll tell you honestly at intake.

How much weight will I lose?

On average about 15% with semaglutide and 20% with tirzepatide at full dose, but results vary a lot. We give you a realistic range for your situation rather than a promise - honest medicine doesn't guarantee numbers.

Will I have to be on it forever?

Obesity is a chronic, relapsing condition, so most people who stop regain most of the weight. Some can move to a lower maintenance dose. Think of it like blood-pressure medicine - a long-term tool for a long-term condition.

Do I have to count calories?

No. The medication lowers your intake by calming appetite. Our coaching focuses on getting enough protein to protect muscle, meal structure, strength training, and sleep - not calorie math.

What if I can't tolerate the side effects?

We slow the dose down first, adjust your meals (smaller, lower-fat, more protein), and if needed switch to the other medication. For the few who can't tolerate any of them, we build a different plan.

The next step

If you're tired of diet cycles and want a clinical relationship instead of a transaction, the $35 consultation is a real 45-minute conversation about your history, your labs, and whether this is the right tool for you. If it isn't, we'll tell you what is.

Arbour Longevity · 2217 Packard St #15, Ann Arbor, MI 48104 · (734) 436-3357 · Thursday through Monday, 10am to 7pm.

References

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM 2021;384:989-1002.
  2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM 2022;387:205-216.
  3. Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). NEJM 2023;389:2221-2232.
  4. Fothergill E, et al. Persistent metabolic adaptation 6 years after “The Biggest Loser” competition. Obesity 2016;24:1612-1619.

This article is educational and does not replace individualized medical advice.

Gandhi Bhattarai, FNP-BC, PMHNP-BC

Gandhi Bhattarai, FNP-BC, PMHNP-BC, Anti-Aging/Functional Medicine BC

Triple board-certified nurse practitioner and founder of Arbour Longevity in Ann Arbor. Every article is written from clinic practice and reviewed against current guidelines.

✓ Medically reviewed · Last updated June 8, 2026

How we reviewed this article

Arbour Longevity articles are written by the treating clinician, checked against primary sources (peer-reviewed journals, FDA labeling, Endocrine Society and other specialty guidelines) and re-reviewed when guidance changes. See our editorial policy. Spotted an error? Email info@arbourlongevity.com.

This article is educational and is not a substitute for individualized medical advice. Whether a treatment is appropriate for you is determined during consultation.

Your next step

Your symptoms have a cause. Let’s find it.

Book a $35 first visit in Ann Arbor. It’s a 30–45 minute consultation with Gandhi Bhattarai, applied toward your plan. Serving Ann Arbor, Ypsilanti, Saline, Dexter, Chelsea, and Michigan by telehealth.

Keep reading

Related articles

Call (734) 436-3357Book $35 visit